Lower prices and high rates of sustainment could make GLP-1 drugs cost-saving for health plans and patients alike
A recent meta-analysis of mixed evidence (5 RCTs 52,183,184,185,186 and 1 cohort study 187 ) in 2,071 people with T2DM or Parkinsons disease suggested antidepressant efficacy of the GLP-1RAs exenatide and liraglutide over 2452 weeks 188
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J
The strongest evidence-based case for GLP-1 therapy is in patients who have both overweight or obesity and established cardiovascular disease
Instead of guessing what will sit well, this guide helps you build simple, digestible protein shakes that support energy, muscle, and consistency even on days when solid food isnt appealing